CNS Response CEO George Carpenter to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

COSTA MESA, CA--(Marketwire - August 25, 2009) - CNS Response, Inc. (OTCBB: CNSO) today announced that its CEO George Carpenter will be presenting at the Rodman & Renshaw 11th Annual Healthcare Conference to be held on September 9 - 11, 2009, at the New York Palace Hotel in New York, NY. Mr. Carpenter's presentation is scheduled for Wednesday, September 9, at 3:15 p.m.

To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of the CNS Response website at http://www.cnsresponse.com, or at http://www.wsw.com/webcast/rrshq15/cnso.ob. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads. An archived replay will be available for 90 days beginning 24 hours after the live presentation.

About CNS Response

Today, most physicians are able to base treatment on objective test data, such as EKGs, MRIs, blood tests, etc. Broadly speaking, such advances have not yet come to those physicians practicing psychiatry.

CNS Response has developed a patented data-analysis capability that, with the help of a simple, non-invasive EEG, will analyze a patient's brain waves and compare the results to an extensive patient outcomes database. The process produces a rEEG® report providing a psychiatrist with guidance to personalize medication regimens for a patient, based on the patient's own brain physiology. To read more about the benefits this patented technology provides physicians, patients and insurers, please visit the CNS Response website, www.cnsresponse.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements involve risks and uncertainties as set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.